{
  "case_id": "Case_5",
  "model_id": "mistralai/mistral-7b-instruct",
  "content": " {\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's disease\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"G20.9\",\n        \"reasoning\": \"Progressive neurological symptoms (tremor, bradykinesia, rigidity) and subtle signal abnormalities in basal ganglia on MRI are consistent with Parkinson's disease. The patient's age and lack of family history also support this diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Multiple system atrophy\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"G22.2\",\n            \"reasoning\": \"Similar neurological symptoms, but MSA typically presents earlier and with autonomic dysfunction which is not reported in this case.\"\n        },\n        {\n            \"name\": \"Hepatic encephalopathy\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"K72.6\",\n            \"reasoning\": \"Possible exposure to environmental toxins during the patient's work in Bangladesh may cause hepatic encephalopathy, but the symptoms and MRI findings are not typical for this condition.\"\n        },\n        {\n            \"name\": \"Wilson's disease\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"E70.0\",\n            \"reasoning\": \"Although rare, Wilson's disease can present with Parkinsonian features. However, the patient's age, lack of family history, and the absence of Kayser-Fleischer rings on examination argue against this diagnosis.\"\n    ],\n    \"key_findings\": [\n        \"Progressive neurological symptoms\",\n        \"Subtle signal abnormalities in basal ganglia on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Dopamine transporter SPECT scan\",\n            \"purpose\": \"To confirm the diagnosis of Parkinson's disease\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Blood tests for liver function\",\n            \"purpose\": \"To rule out hepatic encephalopathy\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Genetic testing for Wilson's disease\",\n            \"purpose\": \"To confirm or rule out Wilson's disease\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Refer to a neurologist\",\n            \"Start symptomatic treatment\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Levodopa/carbidopa\",\n                \"dose\": \"25/100mg PO TID\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"To manage Parkinson's symptoms\"\n            }\n        ],\n        \"monitoring\": [\n            \"Monitor for response to medication\",\n            \"Follow up liver function tests\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For further evaluation and management of the patient's symptoms\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Sudden worsening of symptoms\",\n        \"Cognitive decline\"\n    ],\n    \"patient_education\": [\n        \"Importance of regular follow-ups\",\n        \"Potential side effects of medication\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"3-6 months\",\n        \"conditions\": \"Worsening symptoms or uncontrolled Parkinson's symptoms\"\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"Possible exposure to environmental toxins\",\n        \"Age of onset may be atypical\"\n    ]\n}",
  "latency": 9.038828134536743,
  "timestamp": "2025-08-10T01:17:20.401678",
  "cached_at": "2025-08-10T01:17:20.401681"
}